Drug Shortage Report for PANTOPRAZOLE FOR INJECTION

Last updated on 2025-02-19 History
Report ID 229795
Drug Identification Number 02458969
Brand name PANTOPRAZOLE FOR INJECTION
Common or Proper name PANTOPRAZOLE FOR INJECTION
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10Ml Vial X 10
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-06-06
Estimated end date Unknown
Actual end date 2025-02-18
Shortage status Resolved
Updated date 2025-02-19
Company comments PANTOPRAZOLE FOR INJECTION is now available under Eugia Pharma label (DIN 02528835 ).
Health Canada comments
Tier 3 Status Yes
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-02-19 French Compare
v11 2025-02-19 English Compare
v10 2024-07-22 French Compare
v9 2024-07-22 English Compare
v8 2024-07-15 French Compare
v7 2024-07-15 English Compare
v6 2024-06-25 English Compare
v5 2024-06-18 French Compare
v4 2024-06-18 English Compare
v3 2024-06-07 English Compare
v2 2024-06-06 French Compare
v1 2024-06-06 English Compare

Showing 1 to 12 of 12